BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28168312)

  • 1. Valproic acid-induced hyperammonemic encephalopathy in a full-term neonate: a brief review and case report.
    Pokorná P; Hronová K; Šíma M; Slanař O; Klement P; van den Anker JN; Tibboel D
    Eur J Clin Pharmacol; 2017 May; 73(5):647-649. PubMed ID: 28168312
    [No Abstract]   [Full Text] [Related]  

  • 2. [Valproate-induced hyperammonemic encephalopathy in a neonate: treatment with carglumic acid].
    Fernández Colomer B; Rekarte García S; García López JE; Pérez González C; Montes Granda M; Coto Cotallo GD
    An Pediatr (Barc); 2014 Oct; 81(4):251-5. PubMed ID: 24315420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid and zonisamide induced hyperammonemic encephalopathy.
    Ilieva HS; Newman JW; Fields RK; Croom JE
    Clin Neurol Neurosurg; 2020 Sep; 196():105894. PubMed ID: 32645624
    [No Abstract]   [Full Text] [Related]  

  • 4. Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramate.
    Deutsch SI; Burket JA; Rosse RB
    Clin Neuropharmacol; 2009; 32(6):350-2. PubMed ID: 19952878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report.
    Cheung E; Wong V; Fung CW
    J Child Neurol; 2005 Feb; 20(2):157-60. PubMed ID: 15794187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate-induced Hyperammonemic Encephalopathy Presenting as Catatonia.
    Pérez-Esparza R; Oñate-Cadena N; Ramírez-Bermúdez J; Espínola-Nadurille M
    Neurologist; 2018 Mar; 23(2):51-52. PubMed ID: 29494435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam.
    Lokrantz CM; Eriksson B; Rosén I; Asztely F
    Acta Neurol Scand; 2004 Apr; 109(4):297-301. PubMed ID: 15016014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate-induced hyperammonemic encephalopathy in a renal transplanted patient.
    Melexopoulou C; Marinaki S; Darema M; Skalioti C; Efthimiou A; Zavos G; Boletis JN
    Ren Fail; 2014 Jul; 36(6):955-6. PubMed ID: 24665854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lacosamide-induced valproic acid toxicity.
    Jones GL; Popli GS; Silvia MT
    Pediatr Neurol; 2013 Apr; 48(4):308-10. PubMed ID: 23498565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperammonaemic encephalopathy due to valproic acid in the neonatal period].
    Jiménez-Parrilla F; Pérez-Sánchez A; Núñez-Solís JM; Madruga-Garrido M; Losada-Martínez A
    Rev Neurol; 2009 Jun 1-15; 48(11):613-4. PubMed ID: 19472163
    [No Abstract]   [Full Text] [Related]  

  • 11. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
    Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
    Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulminant Onset of Valproate-Associated Hyperammonemic Encephalopathy.
    Baumgartner J; Hoeflich A; Hinterbuchinger B; Fellinger M; Graf I; Friedrich F; Frey R; Mossaheb N
    Am J Psychiatry; 2019 Nov; 176(11):900-903. PubMed ID: 31672038
    [No Abstract]   [Full Text] [Related]  

  • 13. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
    Rigamonti A; Lauria G; Grimod G; Bianchi G; Salmaggi A
    J Clin Neurosci; 2014 Apr; 21(4):690-1. PubMed ID: 24119342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate-induced hyperammonemic encephalopathy.
    Murphy JV
    Epilepsia; 2003 Feb; 44(2):268; author reply 268. PubMed ID: 12558587
    [No Abstract]   [Full Text] [Related]  

  • 15. Valproate-induced hyperammonemic encephalopathy: a case report and brief review of the literature.
    Sunkavalli KK; Iqbal FM; Singh B; Koneru J
    Am J Ther; 2013; 20(5):569-71. PubMed ID: 21248614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of valproate-induced hyperammonaemic encephalopathy.
    Lucie O; Nazir F; Spilg E
    Scott Med J; 2013 Feb; 58(1):e43-4. PubMed ID: 23596040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate Induced Hyperammonemic Encephalopathy.
    Qayyum W; Yousafzai ZA; Iqbal MS; Khan S; Amin QK; Shafiqs I
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S1038-S1039. PubMed ID: 36550671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burst Suppression Pattern on Electroencephalogram Secondary to Valproic Acid-Induced Hyperammonemic Encephalopathy.
    Cherian KA; Legatt AD
    Pediatr Neurol; 2017 Aug; 73():88-91. PubMed ID: 28545673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate-induced hyperammonemic encephalopathy.
    Verrotti A; Trotta D; Morgese G; Chiarelli F
    Metab Brain Dis; 2002 Dec; 17(4):367-73. PubMed ID: 12602513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperammonaemic encephalopathy and a flat electroencephalogram caused by valproic acid.
    Belze O; Remérand F; Pujol A; Fusciardi J
    Acta Anaesthesiol Scand; 2013 Sep; 57(8):1084. PubMed ID: 23713766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.